Lang Min, Som Avik, Carey Denston, Reid Nicholas, Mendoza Dexter P, Flores Efrén J, Li Matthew D, Shepard Jo-Anne O, Little Brent P
Department of Radiology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114 (M.L., A.S., D.P.M., E.J.F., M.D.L., J.O.S., B.P.L.); and Harvard Medical School, Boston, Mass (D.C., N.R.).
Radiol Cardiothorac Imaging. 2020 Jun 18;2(3):e200277. doi: 10.1148/ryct.2020200277. eCollection 2020 Jun.
To investigate pulmonary vascular abnormalities at CT pulmonary angiography (CT-PE) in patients with coronavirus disease 2019 (COVID-19) pneumonia.
In this retrospective study, 48 patients with reverse-transcription polymerase chain reaction-confirmed COVID-19 infection who had undergone CT-PE between March 23 and April 6, 2020, in a large urban health care system were included. Patient demographics and clinical data were collected through the electronic medical record system. Twenty-five patients underwent dual-energy CT (DECT) as part of the standard CT-PE protocol at a subset of the hospitals. Two thoracic radiologists independently assessed all studies. Disagreement in assessment was resolved by consensus discussion with a third thoracic radiologist.
Of the 48 patients, 45 patients required admission, with 18 admitted to the intensive care unit, and 13 requiring intubation. Seven patients (15%) were found to have pulmonary emboli. Dilated vessels were seen in 41 cases (85%), with 38 (78%) and 27 (55%) cases demonstrating vessel enlargement within and outside of lung opacities, respectively. Dilated distal vessels extending to the pleura and fissures were seen in 40 cases (82%) and 30 cases (61%), respectively. At DECT, mosaic perfusion pattern was observed in 24 cases (96%), regional hyperemia overlapping with areas of pulmonary opacities or immediately surrounding the opacities were seen in 13 cases (52%), opacities associated with corresponding oligemia were seen in 24 cases (96%), and hyperemic halo was seen in 9 cases (36%).
Pulmonary vascular abnormalities such as vessel enlargement and regional mosaic perfusion patterns are common in COVID-19 pneumonia. Perfusion abnormalities are also frequently observed at DECT in COVID-19 pneumonia and may suggest an underlying vascular process.© RSNA, 2020.
研究2019冠状病毒病(COVID-19)肺炎患者行CT肺血管造影(CT-PE)时的肺血管异常情况。
在这项回顾性研究中,纳入了2020年3月23日至4月6日期间在一个大型城市医疗系统中接受CT-PE检查且经逆转录聚合酶链反应确诊为COVID-19感染的48例患者。通过电子病历系统收集患者的人口统计学和临床数据。在部分医院,25例患者作为标准CT-PE检查方案的一部分接受了双能CT(DECT)检查。两名胸部放射科医生独立评估所有检查结果。评估意见分歧通过与第三位胸部放射科医生进行共识讨论来解决。
48例患者中,45例需要住院治疗,其中18例入住重症监护病房,13例需要插管。7例(15%)患者发现有肺栓塞。41例(85%)可见血管扩张,其中38例(78%)和27例(55%)分别在肺实变内和外可见血管增粗。分别有40例(82%)和30例(61%)可见扩张的远端血管延伸至胸膜和叶间裂。在DECT检查中,24例(96%)观察到马赛克灌注模式,13例(52%)可见与肺实变区域重叠或紧邻实变区域的局部充血,24例(96%)可见与相应肺血减少相关的实变,9例(36%)可见充血晕。
肺血管异常,如血管增粗和局部马赛克灌注模式,在COVID-19肺炎中很常见。在COVID-19肺炎的DECT检查中也经常观察到灌注异常,这可能提示潜在的血管病变。©RSNA,2020年。